Literature DB >> 22577171

Kisspeptin administration to women: a window into endogenous kisspeptin secretion and GnRH responsiveness across the menstrual cycle.

Yee-Ming Chan1, James P Butler, Valerie F Sidhoum, Nancy E Pinnell, Stephanie B Seminara.   

Abstract

CONTEXT: Kisspeptin is the most powerful known stimulus of GnRH-induced LH secretion across mammalian species. However, the effects of kisspeptin are just being explored, and the dynamics of kisspeptin responsiveness across the menstrual cycle are incompletely understood.
OBJECTIVE: The objective of the study was to characterize the effects of kisspeptin on GnRH secretion in healthy women in different phases of the menstrual cycle. PARTICIPANTS AND INTERVENTION: Ten women in the early follicular phase, three women in the late follicular (preovulatory) phase, and 14 women in the midluteal phase received a bolus of kisspeptin 112-121 0.24 nmol/kg iv. An additional four women in the early to midfollicular phase received kisspeptin 112-121 0.72 nmol/kg iv.
RESULTS: The response to kisspeptin varied depending on the phase of the menstrual cycle. LH pulses were observed immediately after kisspeptin administration in all luteal and preovulatory women. However, only half the women in the early follicular phase had unambiguous kisspeptin responses. Increasing the kisspeptin dose did not increase the LH response in early to midfollicular phase women. Kisspeptin did not appear to reset the GnRH pulse generator in women as it does in men.
CONCLUSIONS: Differences in responses to exogenous kisspeptin across the menstrual cycle suggest that kisspeptin tone is higher in the early follicular phase compared with other cycle phases. The mechanisms that determine the timing of GnRH pulse generation in men and women appear to be distinct.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22577171      PMCID: PMC3410261          DOI: 10.1210/jc.2012-1282

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  43 in total

1.  The spectrum of abnormal patterns of gonadotropin-releasing hormone secretion in men with idiopathic hypogonadotropic hypogonadism: clinical and laboratory correlations.

Authors:  D I Spratt; D B Carr; G R Merriam; R E Scully; P N Rao; W F Crowley
Journal:  J Clin Endocrinol Metab       Date:  1987-02       Impact factor: 5.958

2.  Intravenous administration of pulsatile gonadotropin-releasing hormone in hypothalamic amenorrhea: effects of dosage.

Authors:  N Santoro; M E Wierman; M Filicori; J Waldstreicher; W F Crowley
Journal:  J Clin Endocrinol Metab       Date:  1986-01       Impact factor: 5.958

3.  Variation of pituitary responsiveness to synthetic LRF during different phases of the menstrual cycle.

Authors:  S S Yen; G VandenBerg; R Rebar; Y Ehara
Journal:  J Clin Endocrinol Metab       Date:  1972-12       Impact factor: 5.958

4.  Variation in LH and FSH response to LH-releasing hormone during the menstrual cycle.

Authors:  S J Nillius; L Wide
Journal:  J Obstet Gynaecol Br Commonw       Date:  1972-10

5.  Effects of estrogen and progesterone on pituitary response to stimulation by luteinizing hormone-releasing factor.

Authors:  I E Thompson; J Arfania; M L Taymor
Journal:  J Clin Endocrinol Metab       Date:  1973-07       Impact factor: 5.958

6.  Response of pituitary LH and FSH to synthetic LH-releasing hormone in normal subjects and patients with Sheehan's syndrome.

Authors:  T Aono; J Minagawa; T Kinugasa; O Tanizawa; K Kurachi
Journal:  Am J Obstet Gynecol       Date:  1973-12-15       Impact factor: 8.661

7.  Direct evidence of estrogen modulation of pituitary sensitivity to luteinizing hormone-releasing factor during the menstrual cycle.

Authors:  C F Wang; S S Yen
Journal:  J Clin Invest       Date:  1975-01       Impact factor: 14.808

8.  Episodic luteinizing hormone secretion in man. Pulse analysis, clinical interpretation, physiologic mechanisms.

Authors:  R J Santen; C W Bardin
Journal:  J Clin Invest       Date:  1973-10       Impact factor: 14.808

9.  Interpulse interval sequence of LH in normal men essentially constitutes a renewal process.

Authors:  J P Butler; D I Spratt; L S O'Dea; W F Crowley
Journal:  Am J Physiol       Date:  1986-03

10.  The effect of hypothalamic luteinizing hormone releasing hormone (LH-RH) on plasma gonadotrophin levels in normal subjects.

Authors:  P Franchimont; H Becker; C Ernould; C Thys; A Demoulin; J P Bourguignon; J J Legros; J C Valcke
Journal:  Clin Endocrinol (Oxf)       Date:  1974-01       Impact factor: 3.478

View more
  27 in total

Review 1.  Kisspeptin signalling in the physiology and pathophysiology of the urogenital system.

Authors:  Fazal Wahab; Bibi Atika; Muhammad Shahab; Rüdiger Behr
Journal:  Nat Rev Urol       Date:  2015-12-01       Impact factor: 14.432

2.  Hypothalamic Reproductive Endocrine Pulse Generator Activity Independent of Neurokinin B and Dynorphin Signaling.

Authors:  Margaret F Lippincott; Silvia León; Yee-Ming Chan; Chrysanthi Fergani; Rajae Talbi; I Sadaf Farooqi; Christopher M Jones; Wiebke Arlt; Susan E Stewart; Trevor R Cole; Ei Terasawa; Janet E Hall; Natalie D Shaw; Victor M Navarro; Stephanie Beth Seminara
Journal:  J Clin Endocrinol Metab       Date:  2019-10-01       Impact factor: 5.958

3.  Continuous Kisspeptin Administration in Postmenopausal Women: Impact of Estradiol on Luteinizing Hormone Secretion.

Authors:  Margaret F Lippincott; Yee-Ming Chan; Dianali Rivera Morales; Stephanie B Seminara
Journal:  J Clin Endocrinol Metab       Date:  2017-06-01       Impact factor: 5.958

Review 4.  Pubertal development and regulation.

Authors:  Ana Paula Abreu; Ursula B Kaiser
Journal:  Lancet Diabetes Endocrinol       Date:  2016-02-04       Impact factor: 32.069

Review 5.  Kisspeptin and the hypothalamic control of reproduction: lessons from the human.

Authors:  Jyothis T George; Stephanie B Seminara
Journal:  Endocrinology       Date:  2012-09-26       Impact factor: 4.736

6.  Disrupted kisspeptin signaling in GnRH neurons leads to hypogonadotrophic hypogonadism.

Authors:  Horacio J Novaira; Momodou L Sonko; Gloria Hoffman; Yongbum Koo; Chemyong Ko; Andrew Wolfe; Sally Radovick
Journal:  Mol Endocrinol       Date:  2014-01-01

Review 7.  Kallmann syndrome: phenotype and genotype of hypogonadotropic hypogonadism.

Authors:  Maria I Stamou; Neoklis A Georgopoulos
Journal:  Metabolism       Date:  2017-11-03       Impact factor: 8.694

8.  Divergent responses to kisspeptin in children with delayed puberty.

Authors:  Yee-Ming Chan; Margaret F Lippincott; Temitope O Kusa; Stephanie B Seminara
Journal:  JCI Insight       Date:  2018-04-19

9.  Low degree of overlap between kisspeptin, neurokinin B, and dynorphin immunoreactivities in the infundibular nucleus of young male human subjects challenges the KNDy neuron concept.

Authors:  Erik Hrabovszky; Máté T Sipos; Csilla S Molnár; Philippe Ciofi; Beáta Á Borsay; Péter Gergely; László Herczeg; Stephen R Bloom; Mohammad A Ghatei; Waljit S Dhillo; Zsolt Liposits
Journal:  Endocrinology       Date:  2012-08-17       Impact factor: 4.736

10.  Using Kisspeptin to Predict Pubertal Outcomes for Youth With Pubertal Delay.

Authors:  Yee-Ming Chan; Margaret F Lippincott; Priscila Sales Barroso; Cielo Alleyn; Jill Brodsky; Hector Granados; Stephanie A Roberts; Courtney Sandler; Abhinash Srivatsa; Stephanie B Seminara
Journal:  J Clin Endocrinol Metab       Date:  2020-08-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.